JLJeffrey N. Levy

Jeffrey N. Levy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeffrey N. Levy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Broadly Applicable Strategy to Aminate Azines Enabled by Electronically Tuned Phosphine Reagents

    by Ren‐Rong Liu, Jeffrey N. Levy, Andrew McNally

    We describe a strategy for aminating pyridines and other azines via phosphonium salt intermediates. Precisely tuning the electronic properties of the phosphonium ion was key for C─N bond formation via an SNAr‐halogenation, SNAr‐amination sequence. The process couples a wide range of amine classes with pyridines and is viable for applications such as late‐stage amination of complex pharmaceuticals and fragment–fragment coupling reactions. The capacity to rapidly modify the structure of the phosphine reagent was decisive and is a valuable feature in pseudohalide design.

  • Open Access

    A Broadly Applicable Strategy to Aminate Azines Enabled by Electronically Tuned Phosphine Reagents

    by Ren‐Rong Liu, Jeffrey N. Levy, Andrew McNally

    We describe a strategy for aminating pyridines and other azines via phosphonium salt intermediates. Precisely tuning the electronic properties of the phosphonium ion was key for C─N bond formation via an SNAr‐halogenation, SNAr‐amination sequence. The process couples a wide range of amine classes with pyridines and is viable for applications such as late‐stage amination of complex pharmaceuticals and fragment–fragment coupling reactions. The capacity to rapidly modify the structure of the phosphine reagent was decisive and is a valuable feature in pseudohalide design.


  • Top Cited Papers

    Halogenation of the 3-position of pyridines through Zincke imine intermediates

    by Benjamin T. Boyle, Jeffrey N. Levy, Louis de Lescure, Robert S. Paton, Andrew McNally

    Pyridine halogenation reactions are crucial for obtaining the vast array of derivatives required for drug and agrochemical development. However, despite more than a century of synthetic endeavors, halogenation processes that selectively functionalize the carbon–hydrogen bond in the 3-position of a broad range of pyridine precursors remain largely elusive. We report a reaction sequence of pyridyl ring opening, halogenation, and ring closing whereby the acyclic Zincke imine intermediates undergo highly regioselective halogenation reactions under mild conditions. Experimental and computational mechanistic studies indicate that the nature of the halogen electrophile can modify the selectivity-determining step. Using this method, we produced a diverse set of 3-halopyridines and demonstrated late-stage halogenation of complex pharmaceuticals and agrochemicals.


  • Open Access

    Phosphorus-Mediated sp2-sp3 Couplings for Selective C–H Fluoroalkylation of Complex Azines

    by Xuan Zhang, Kyle G. Nottingham, Chirag Patel, Juan V. Alegre-Requena, Jeffrey N. Levy, Robert S. Paton, Andrew McNally

    Fluoroalkyl groups profoundly affect the physical properties of pharmaceuticals and influence virtually all metrics associated with their pharmacokinetic and pharmacodynamic profile.1-4 Drug candidates increasingly contain CF3 and CF2H groups, and the same trend in agrochemical development shows that the effect of fluoroalkylation translates across human, insect, and plant life.5,6 New fluoroalkylation reactions have undoubtedly stimulated this uptake; however, methods that directly convert C–H bonds into C–CF2X (X = F or H) groups in complex drug-like molecules are rare.7-13 For pyridine, the most common aromatic heterocycle in pharmaceuticals,14 only one approach, via fluoroalkyl radicals, is viable for pyridyl C–H fluoroalkylation in the elaborate structures encountered during drug development.15-17 Here, we have developed a new set of bench-stable fluoroalkylphosphines that directly convert the C–H bonds in pyridine building blocks, drug-like fragments, and pharmaceuticals into fluoroalkyl derivatives. No pre-installed functional groups or directing groups are required; the reaction tolerates a variety of sterically and electronically distinct pyridines and is exclusively selective for the 4-position in most cases. The reaction proceeds via initial phosphonium salt formation followed by sp2-sp3 phosphorus ligand-coupling, an underdeveloped manifold for C–C bond formation.

  • Selective Halogenation of Pyridines Using Designed Phosphine Reagents

    by Jeffrey N. Levy, Juan V. Alegre-Requena, Renrong Liu, Robert S. Paton, Andrew McNally

    Halopyridines are key building blocks for synthesizing pharmaceuticals, agrochemicals, and ligands for metal complexes, but strategies to selectively halogenate pyridine C–H precursors are lacking. We designed a set of heterocyclic phosphines that are installed at the 4-position of pyridines as phosphonium salts and then displaced with halide nucleophiles. A broad range of unactivated pyridines can be halogenated, and the method is viable for late-stage halogenation of complex pharmaceuticals. Computational studies indicate that C–Halogen bond formation occurs via an SNAr pathway, and phosphine elimination is the rate-determining step. Steric interactions during C–P bond cleavage account for differences in reactivity between 2- and 3-substituted pyridines


  • Open Access

    Selective Halogenation of Pyridines Using Designed Phosphine Reagents

    by Jeffrey N. Levy, Ren-Rong Liu, Andrew McNally

    Halopyridines are key building blocks for synthesizing pharmaceuticals, agrochemicals, and ligands for metal complexes, but strategies to selectively halogenate pyridine C–H precursors are lacking. We designed a set of heterocyclic phosphines that are selectively installed at the 4-position of pyridines as phosphonium salts and then displaced with halide nucleophiles. A broad range of unactivated pyridines can be halogenated, and the method is viable for late-stage halogenation of complex pharmaceuticals. The study concludes that both tuning the phosphonium electrophilicity and pyridine substitution patterns influence the efficiency of the carbon-halogen bond-forming step.

  • Open Access

    Expedient synthesis of eumelanin-inspired 5,6-dihydroxyindole-2-carboxylate ethyl ester derivatives

    by Andrew H. Aebly, Jeffrey N. Levy, Benjamin J. Steger, Jonathan C. Quirke, Jason M. Belitsky

    Two concise syntheses of novel aryl- and heteroaryl-substituted 5,6-dimethoxyindole-2-carboxylate ethyl esters utilizing regioselective halogenation/dehalogenation and Suzuki coupling are presented.